http://woodlandsonline.com/npps/story.cfm?nppage=26324
Quote:
The company announced that it will use the proceeds from the financing to support the ongoing clinical development of Tovaxin,
|
This is good news! Now they can start recruiting for the Phase III trials which, from what I understand, will include 3-5000 patients and possibly both RRMS and SPMS. Don't quote me on that, but that's what I have heard!!
Here's a second article.
http://houston.bizjournals.com/houst...1/daily21.html
Now if I could just make those MRTCs to continue in the extension study I would be happy!!! September 24th is my next magic day!!!